-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Palisade Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Palisade Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.59M, a 4.9% increase year-over-year.
- Palisade Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$14.6M, a 6.3% decline year-over-year.
- Palisade Bio, Inc. annual Operating Income (Loss) for 2023 was -$13.1M, a 16.9% increase from 2022.
- Palisade Bio, Inc. annual Operating Income (Loss) for 2022 was -$15.7M, a 62.4% increase from 2021.
- Palisade Bio, Inc. annual Operating Income (Loss) for 2021 was -$41.9M, a 350% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)